Th1 and Th2 cytokines in a self-healing primary pulmonary Aspergillus flavus infection in BALB/c mice

Cytokine

Volumn 52, Issue 3, 2010, Pages 258-264

  Anand, Rajesh ^a   Tiwary, Bhupendra Nath ^b  

^a PATNA UNIVERSITY   (India)

^b GURU GHASIDAS UNIVERSITY   (India)

Author keywords

Aspergillus flavus; BALB c mice; Bronchoalveolar lavage fluid; Pulmonary infection; Th1 and Th2 cytokines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FLAVUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEALING; HISTOPATHOLOGY; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; LUNG ASPERGILLOSIS; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; ANIMAL; ASPERGILLOSIS; BAGG ALBINO MOUSE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG LAVAGE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ASPERGILLUS; ASPERGILLUS FLAVUS; FUNGI; MAMMALIA; MUS;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; MICE; MICE, INBRED BALB C; TH1 CELLS; TH2 CELLS;

EID: 79953315034     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.07.428     Document Type: Article

References (46)

1. Ford S., Friedman L. Experimental study of the pathogenicity of aspergilli for mice. J Bacteriol 1967, 94:928-933.
2. Mosquera J., Warn P.A., Morrissey J., Moore C.B., Gil-Lamaignere C., Denning D.W. Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo. Antimicrob Agents Chemother 2000, 45:1456-1462.
3. Kamai Y., Harasaki T., Fukuoka T., Ohya S., Uchida K., Yamaguchi H., et al. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent. Antimicrob Agents Chemother 2002, 46:367-370.
4. Kaliamurthy J., Geraldine J.P., Thomas P.A. Disseminated aspergillosis due to Aspergillus flavus in an experimental model: efficacy of azole therapy. Mycoses 2003, 46:174-182.
5. Denning D.W. Invasive aspergillosis. Clin Infect Dis 1998, 26:781-803.
6. Morgan J., Wannemuehler K.A., Marr K.A., Hadley S., Kontoyiannis D.P., Walsh T.J., et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005, 43(Suppl. 1):S49-S58.
7. Khan Z.U., Sandhu R.S., Randhawa H.S., Menon M.P., Dusaj I.S. Allergic bronchopulmonary aspergillosis: a study of 46 cases with special reference to laboratory aspects. Scand J Respir Dis 1976, 57:73-87.
8. Chakrabarti A., Sethi S., Raman D.S., Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 2002, 45:295-299.
9. Liao W.Q., Shao J.Z., Li S.Q., Wan G.T., Da Z.W., Sun Y.C., et al. Mycological identification of pulmonary aspergilloma caused by Aspergillus oryzae with proliferating heads. Chin Med J (Engl) 1998, 101:601-604.
10. Staib F., Rajendran C., Mishra S.K., Voigt R., Lindlar F., Hartmann C., Weber R., Nowotny P. An atypical Aspergillus flavus from a case of bronchopulmonary aspergilloma. A contribution to the cultural and serological diagnosis of A. flavus infections. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983, 255:361-367.
11. Chakrabarti A., Sharma S.C., Chandler J. Epidemiology and pathogenesis of paranasal sinus mycoses. Otolaryngol Head Neck Surg 1992, 107:745-750.
12. Hussain S., Salahuddin N., Ahmad I., Salahuddin I., Jooma R. Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. Eur J Radiol 1995, 20:151-155.
13. Iwen P.C., Rupp M.E., Hinrichs S.H. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997, 24:1178-1184.
14. Kennedy C.A., Adams G.L., Neglia J.P., Giebink G.S. Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients. Otolaryngol Head Neck Surg 1997, 116:610-616.
15. Panda N.K., Sharma S.C., Chakrabarti A., Mann S.B. Paranasal sinus mycoses in north India. Mycoses 1998, 41:281-286.
16. Hope W.W., Walsh T.J., Denning D.W. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005, 43(Suppl. 1):S207-S238.
17. Milosev B., el-Mahgoub S., Aal O.A., el-Hassan A.M. Primary aspergilloma of paranasal sinuses in the Sudan. A review of seventeen cases. Br J Surg 1969, 56:132-137.
18. Gumaa S.A., Mahgoub E.S., Hay R.J. Post-operative responses of paranasal Aspergillus granuloma to itraconazole. Trans R Soc Trop Med Hyg 1992, 86:93-94.
19. Yagi H.I., Gumaa S.A., Shumo A.I., Abdalla N., Gadir A.A. Nasosinus aspergillosis in Sudanese patients: clinical features, pathology, diagnosis, and treatment. J Otolaryngol 1999, 28:90-94.
20. Alrajhi A.A., Enani M., Mahasin Z., Al-Omran K. Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. Am J Trop Med Hyg 2001, 65:83-86.
21. Ramani R., Hazarika P., Kapadia R.D., Shivananda P.G. Invasive maxillary aspergillosis in an otherwise healthy individual. Ear Nose Throat J 1994, 73:420-422.
22. Panda N.K., Balaji P., Chakrabarti A., Sharma S.C., Reddy C.E. Paranasal sinus aspergillosis: its categorization to develop a treatment protocol. Mycoses 2004, 47:277-283.
23. Taj-Aldeen S.J., Hilal A.A., Chong-Lopez A. Allergic Aspergillus flavus rhinosinusitis: a case report from Qatar. Eur Arch Otorhinolaryngol 2003, 260:331-335.
24. Taj-Aldeen S.J., Hilal A.A., Schell W.A. Allergic fungal rhinosinusitis: a report of 8 cases. Am J Otolaryngol 2004, 25:213-218.
25. Saravanan K., Panda N.K., Chakrabarti A., Das A., Bapuraj R.J. Allergic fungal rhinosinusitis: an attempt to resolve the diagnostic dilemma. Arch Otolaryngol Head Neck Surg 2006, 132:173-178.
26. Thakar A., Sarkar C., Dhiwakar M., Bahadur S., Dahiya S. Allergic fungal sinusitis: expanding the clinicopathologic spectrum. Otolaryngol Head Neck Surg 2004, 130:209-216.
27. Hedayati M.T., Pasqualotto A.C., Warn P.A., Bowyer P., Denning D.W. Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology 2007, 153:1677-1692.
28. Powrie F., Coffman R.L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993, 14:270-274.
29. Goettel S., Inglis G.D. Fungi: hyphomycetes. Manual of techniques in insect pathology 1997, Academic Press, London. L.A. Lacey (Ed.).
30. Hatch G.E., Slade R., Boykin E., Hu P.C., Miller F.J., Gardner D.E. Correlation of effects of inhaled versus intratracheally injected metals on susceptibility to respiratory infection in mice. Am Rev Respir Dis 1981, 124:167-173.
31. Blanchard D.K., Djeu J.Y., Klein T.W., Friedman H., Stewart W.E. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol 1988, 43:429-435.
32. Cenci E., Mencacci A., Fe' d'Ostiani C., Del Sero G., Mosci P., Montagnoli C., et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998, 178:1750-1760.
33. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993, 177:547-550.
34. de Vries J.E. Immunosuppressive and anti-inflammatory properties of interleukin-10. Ann Med 1995, 27:537-541.
35. Roilides E., Dimitriadou-Georgiadou A., Sein T., Kadiltsoglou I., Walsh T.J. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998, 66:5999-6003.
36. Kawakami K., Qureshi M.H., Koguchi Y., Zhang T., Okamura H., Kurimoto M. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. Cell Immunol 1999, 193:9-16.
37. Mencacci A., Cenci E., Bacci A., Montagnoli C., Bistoni F., Romani L. Cytokines in candidiasis and aspergillosis. Curr Pharmceutical Biotechnol 2000, 1:235-251.
38. Bauman S.K., Huffnagle G.B., Murphy J.W. Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 2003, 71:68-74.
39. Gaviria J.M., van Burik J.A., Dale D.C., Root R.K., Liles W.C. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999, 179:1038-1041.
40. Cenci E., Mencacci A., Del Sero G., d'Ostiani C.F., Mosci P., Bacci A., et al. IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J Immunol 1998, 161:3543-3550.
41. Netea M.G., Kullberg B.J., Van der Meer J.W. Proinflammatory cytokines in the treatment of bacterial and fungal infections. BioDrugs 2004, 18:9-22.
42. Cenci E., Mencacci A., Del Sero G., Bacci A., Montagnoli C., Fè d'Ostiani C., et al. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 1999, 180:1957-1968.
43. Romani L., Puccetti P., Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev 1997, 10:611-636.
44. Bistoni F., Cenci E., Mencacci A., Schiaffella E., Mosci P., Puccetti P., et al. Mucosal and systemic T helper cell functions after intragastric colonization of adult mice with Candida albicans. J Infect Dis 1993, 168:1449-1457.
45. Cenci E., Mencacci A., Spaccapelo R., Tonnetti L., Mosci P., Enssle K.H., et al. T helper cell type 1 (Th1) - and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995, 171:1279-1288.
46. Standiford T.J., Kunkel S.L., Greenberger M.J., Laichalk L.L., Strieter R.M. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996, 59:24-28.